Supplemental material, sj-docx-1-saj-10.1177_29767342231208823 for Regional Variation in Opioid-Related Emergency Medical Services Transfers During the COVID-19 Pandemic: An Interrupted Time Series Analysis by Sahar Yazdanfard, Douglas Thornton, Prachet Bhatt, Bilqees Fatima, Javeria Khalid, Juhyeon Song and Tyler Jordan Varisco in Substance Abuse</p
Supplemental material, sj-docx-1-saj-10.1177_29767342231212790 for An Assessment of the One-Month Ef...
Supplemental material, sj-docx-1-saj-10.1177_29767342231210552 for High Interest in Injectable Opioi...
Supplemental material, sj-xlsx-2-tak-10.1177_17539447221137170 for Impact of the COVID-19 pandemic o...
Supplemental material, sj-docx-1-sat-10.1177_11782218221135875 for Surveying Over the Counter and Pr...
Supplemental material, sj-docx-1-saj-10.1177_29767342231208516 for Utilization of Medications for Op...
Supplemental material, sj-docx-5-tak-10.1177_17539447221137170 for Impact of the COVID-19 pandemic o...
Supplemental material, sj-docx-1-sat-10.1177_11782218221138335 for Predictors of Retention and Drug ...
Supplemental material, sj-docx-1-imj-10.1177_10815589231220573 for Epidemiology and outcomes of prev...
Supplemental material, sj-docx-1-isp-10.1177_00207640231185026 for Provision of community mental hea...
Supplemental material, sj-docx-1-jpx-10.1177_23743735211034973 for Patient Experiences With Telemedi...
Supplemental material, sj-docx-1-jpx-10.1177_23743735231151539 for Patient Experiences with a Tertia...
Supplemental material, sj-docx-1-smo-10.1177_20503121221129918 for Persistence of COVID-19 symptoms ...
Supplemental material, sj-xlsx-3-tak-10.1177_17539447221137170 for Impact of the COVID-19 pandemic o...
Supplemental material, sj-docx-1-dhj-10.1177_20552076221121529 for Analyzing opioid-use disorder web...
Supplemental material, sj-xlsx-1-tak-10.1177_17539447221137170 for Impact of the COVID-19 pandemic o...
Supplemental material, sj-docx-1-saj-10.1177_29767342231212790 for An Assessment of the One-Month Ef...
Supplemental material, sj-docx-1-saj-10.1177_29767342231210552 for High Interest in Injectable Opioi...
Supplemental material, sj-xlsx-2-tak-10.1177_17539447221137170 for Impact of the COVID-19 pandemic o...
Supplemental material, sj-docx-1-sat-10.1177_11782218221135875 for Surveying Over the Counter and Pr...
Supplemental material, sj-docx-1-saj-10.1177_29767342231208516 for Utilization of Medications for Op...
Supplemental material, sj-docx-5-tak-10.1177_17539447221137170 for Impact of the COVID-19 pandemic o...
Supplemental material, sj-docx-1-sat-10.1177_11782218221138335 for Predictors of Retention and Drug ...
Supplemental material, sj-docx-1-imj-10.1177_10815589231220573 for Epidemiology and outcomes of prev...
Supplemental material, sj-docx-1-isp-10.1177_00207640231185026 for Provision of community mental hea...
Supplemental material, sj-docx-1-jpx-10.1177_23743735211034973 for Patient Experiences With Telemedi...
Supplemental material, sj-docx-1-jpx-10.1177_23743735231151539 for Patient Experiences with a Tertia...
Supplemental material, sj-docx-1-smo-10.1177_20503121221129918 for Persistence of COVID-19 symptoms ...
Supplemental material, sj-xlsx-3-tak-10.1177_17539447221137170 for Impact of the COVID-19 pandemic o...
Supplemental material, sj-docx-1-dhj-10.1177_20552076221121529 for Analyzing opioid-use disorder web...
Supplemental material, sj-xlsx-1-tak-10.1177_17539447221137170 for Impact of the COVID-19 pandemic o...
Supplemental material, sj-docx-1-saj-10.1177_29767342231212790 for An Assessment of the One-Month Ef...
Supplemental material, sj-docx-1-saj-10.1177_29767342231210552 for High Interest in Injectable Opioi...
Supplemental material, sj-xlsx-2-tak-10.1177_17539447221137170 for Impact of the COVID-19 pandemic o...